Tex. Occ. Code § 562.153

Current with legislation from the 2023 Regular and Special Sessions signed by the Governor as of November 21, 2023.

Section 562.153 - Requirements for Office Use Compounding

To dispense and deliver a compounded drug under Section 562.152, a pharmacy must:

(1) verify the source of the raw materials to be used in a compounded drug;

(2) comply with applicable United States Pharmacopoeia guidelines, including the testing requirements, and the Health Insurance Portability and Accountability Act of 1996 ( Pub. L. No. 104-191 );

(3) comply with all applicable competency and accrediting standards as determined by the board; and

(4) comply with board rules, including rules regarding the reporting of adverse events by practitioners and recall procedures for compounded products.

Tex. Occ. Code § 562.153

Amended By Acts 2005, 79th Leg., Ch. 28, Sec. 4, eff. 9/1/2005.